Literature DB >> 4001843

Increased intestinal hydrolysis of urea in patients with alcoholic cirrhosis.

B A Hansen, H Vilstrup.   

Abstract

Fourteen patients with biopsy-proven alcoholic liver cirrhosis in a clinically stable phase but with compromised liver function entered the study, together with 10 control persons. All had normal creatinine clearance, and none received antibiotics or hormones. They ingested a diet containing 1 g of protein/kg body weight daily during the study. The fractional intestinal loss of newly synthesized urea, determined by a 14C-urea tracer method, was increased from 0.17 +/- 0.08 in controls to 0.26 +/- 0.08 in cirrhotics (mean +/- SD, P less than 0.02). Urea nitrogen synthesis rate, determined as urinary excretion rate, corrected for accumulation in the total body water and for fractional intestinal loss, was the same in controls and cirrhotics (26.1 +/- 3.8 and 22.1 +/- 6.8 mmol/h, respectively). The patients with cirrhosis had a significantly greater nitrogen balance than the control group (12.5 +/- 7.0 mmol/h versus 7.0 +/- 5.9 mmol/h; P less than 0.05). Furthermore, there was a positive correlation between intestinal loss and blood urea nitrogen concentration (r = 0.68, P less than 0.01) in patients with cirrhosis but not in controls. The increased endogenous ammonia load of cirrhotics corresponds to an extra protein intake of 30-35 g/day. In patients with cirrhosis prophylactic treatment with, for example, lactulose is rational before reduction in dietary protein.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4001843     DOI: 10.3109/00365528509091662

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  10 in total

1.  Dietary fiber in conservative management of chronic renal failure.

Authors:  Donna Zimmaro Bliss
Journal:  Pediatr Nephrol       Date:  2004-08-04       Impact factor: 3.714

Review 2.  Gut microbiota: its role in hepatic encephalopathy.

Authors:  Rahul Rai; Vivek A Saraswat; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2014-12-16

Review 3.  Chronic portal systemic encephalopathy: update 1987.

Authors:  S Sherlock
Journal:  Gut       Date:  1987-08       Impact factor: 23.059

4.  Human (13)N-ammonia PET studies: the importance of measuring (13)N-ammonia metabolites in blood.

Authors:  Susanne Keiding; Michael Sørensen; Ole Lajord Munk; Dirk Bender
Journal:  Metab Brain Dis       Date:  2010-03-09       Impact factor: 3.584

5.  Increased amino acid clearance and urea synthesis in a patient with glucagonoma.

Authors:  T P Almdal; H Heindorff; L Bardram; H Vilstrup
Journal:  Gut       Date:  1990-08       Impact factor: 23.059

6.  Elective laparoscopic cholecystectomy nearly abolishes the postoperative hepatic catabolic stress response.

Authors:  H Glerup; H Heindorff; A Flyvbjerg; S L Jensen; H Vilstrup
Journal:  Ann Surg       Date:  1995-03       Impact factor: 12.969

Review 7.  The role of the gut microbiome in chronic liver disease: the clinical evidence revised.

Authors:  Katherine Jp Schwenger; Nayima Clermont-Dejean; Johane P Allard
Journal:  JHEP Rep       Date:  2019-07-31

Review 8.  The Direct Contribution of Astrocytes and Microglia to the Pathogenesis of Hepatic Encephalopathy.

Authors:  Victoria Jaeger; Sharon DeMorrow; Matthew McMillin
Journal:  J Clin Transl Hepatol       Date:  2019-11-13

9.  Probiotics improve the neurometabolic profile of rats with chronic cholestatic liver disease.

Authors:  Veronika Rackayová; Emmanuelle Flatt; Olivier Braissant; Jocelyn Grosse; Daniela Capobianco; Paola Mastromarino; Matthew McMillin; Sharon DeMorrow; Valérie A McLin; Cristina Cudalbu
Journal:  Sci Rep       Date:  2021-01-26       Impact factor: 4.379

Review 10.  The Link between Gut Microbiota and Hepatic Encephalopathy.

Authors:  Sung-Min Won; Ki Kwang Oh; Haripriya Gupta; Raja Ganesan; Satya Priya Sharma; Jin-Ju Jeong; Sang Jun Yoon; Min Kyo Jeong; Byeong Hyun Min; Ji Ye Hyun; Hee Jin Park; Jung A Eom; Su Been Lee; Min Gi Cha; Goo Hyun Kwon; Mi Ran Choi; Dong Joon Kim; Ki Tae Suk
Journal:  Int J Mol Sci       Date:  2022-08-12       Impact factor: 6.208

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.